January 29, 2024 / 10:16 IST
Reported Consolidated quarterly numbers for Astec Lifesciences are:Net Sales at Rs 50.79 crore in December 2023 down 56.65% from Rs. 117.18 crore in December 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 24.33 crore in December 2023 down 2997.96% from Rs. 0.84 crore in December 2022.
EBITDA stands negative at Rs. 17.42 crore in December 2023 down 209.42% from Rs. 15.92 crore in December 2022.
Astec Life shares closed at 1,001.35 on January 25, 2024 (NSE) and has given -20.68% returns over the last 6 months and -37.93% over the last 12 months.
Astec Lifesciences | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | Net Sales/Income from operations | 50.79 | 110.79 | 117.18 | Other Operating Income | -- | -- | -- | Total Income From Operations | 50.79 | 110.79 | 117.18 | EXPENDITURE | Consumption of Raw Materials | 43.17 | 72.38 | 111.02 | Purchase of Traded Goods | -- | -- | -- | Increase/Decrease in Stocks | -7.85 | 3.64 | -41.30 | Power & Fuel | -- | -- | -- | Employees Cost | 14.43 | 17.25 | 11.40 | Depreciation | 8.70 | 9.16 | 8.80 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 19.38 | 20.94 | 23.94 | P/L Before Other Inc., Int., Excpt. Items & Tax | -27.03 | -12.58 | 3.33 | Other Income | 0.91 | 0.98 | 3.79 | P/L Before Int., Excpt. Items & Tax | -26.12 | -11.60 | 7.12 | Interest | 6.09 | 5.99 | 5.88 | P/L Before Exceptional Items & Tax | -32.22 | -17.60 | 1.24 | Exceptional Items | -- | -- | -- | P/L Before Tax | -32.22 | -17.60 | 1.24 | Tax | -7.89 | -4.18 | 0.39 | P/L After Tax from Ordinary Activities | -24.33 | -13.42 | 0.85 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -24.33 | -13.42 | 0.85 | Minority Interest | -0.01 | -0.01 | -0.01 | Share Of P/L Of Associates | -- | -- | -- | Net P/L After M.I & Associates | -24.33 | -13.43 | 0.84 | Equity Share Capital | 19.61 | 19.61 | 19.61 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -12.41 | -6.85 | 0.43 | Diluted EPS | -12.41 | -6.85 | 0.43 | EPS After Extra Ordinary | Basic EPS | -12.41 | -6.85 | 0.43 | Diluted EPS | -12.41 | -6.85 | 0.43 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!